Categorization of COVID-19 severity to determine mortality risk

被引:9
|
作者
Garry, Elizabeth M. [1 ]
Weckstein, Andrew R. [1 ]
Quinto, Kenneth [2 ]
Bradley, Marie C. [3 ]
Lasky, Tamar [4 ]
Chakravarty, Aloka [4 ]
Leonard, Sandy [5 ]
Vititoe, Sarah E. [1 ]
Easthausen, Imaani J. [1 ]
Rassen, Jeremy A. [1 ]
Gatto, Nicolle M. [1 ]
机构
[1] Aetion Inc, New York, NY 10001 USA
[2] US FDA, Off Med Policy, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[3] US FDA, Div Epidemiol, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[4] US FDA, Off Commissioner, Silver Spring, MD USA
[5] HealthVerity, Partnerships & RWD, Philadelphia, PA USA
关键词
administrative claims; healthcare; COVID-19; severity of illness index;
D O I
10.1002/pds.5436
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose Algorithms for classification of inpatient COVID-19 severity are necessary for confounding control in studies using real-world data. Methods Using Healthverity chargemaster and claims data, we selected patients hospitalized with COVID-19 between April 2020 and February 2021, and classified them by severity at admission using an algorithm we developed based on respiratory support requirements (supplemental oxygen or non-invasive ventilation, O2/NIV, invasive mechanical ventilation, IMV, or NEITHER). To evaluate the utility of the algorithm, patients were followed from admission until death, discharge, or a 28-day maximum to report mortality risks and rates overall and by stratified by severity. Trends for heterogeneity in mortality risk and rate across severity classifications were evaluated using Cochran-Armitage and Logrank trend tests, respectively. Results Among 118 117 patients, the algorithm categorized patients in increasing severity as NEITHER (36.7%), O2/NIV (54.3%), and IMV (9.0%). Associated mortality risk (and 95% CI) was 11.8% (11.6-12.0%) overall and increased with severity [3.4% (3.2-3.5%), 11.5% (11.3-11.8%), 47.3% (46.3-48.2%); p < 0.001]. Mortality rate per 1000 person-days (and 95% CI) was 15.1 (14.9-15.4) overall and increased with severity [5.7 (5.4-6.0), 14.5 (14.2-14.9), 32.7 (31.8-33.6); p < 0.001]. Conclusion As expected, we observed a positive association between the algorithm-defined severity on admission and 28-day mortality risk and rate. Although performance remains to be validated, this provides some assurance that this algorithm may be used for confounding control or stratification in treatment effect studies.
引用
收藏
页码:721 / 728
页数:8
相关论文
共 50 条
  • [1] Categorization of COVID-19 severity to determine mortality risk
    Garry, Elizabeth M.
    Weckstein, Andrew R.
    Quinto, Kenneth
    Bradley, Marie C.
    Lasky, Tamar
    Leonard, Sandy
    Vititoe, Sarah
    Gatto, Nicolle M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 91 - 91
  • [2] Arterial hypertension and the risk of severity and mortality of COVID-19
    Leiva Sisnieguez, Carlos Enrique
    Gaston Espeche, Walter
    Rogelio Salazar, Martin
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (06)
  • [3] A risk index for COVID-19 severity is associated with COVID-19 mortality in New York City
    Wil Lieberman-Cribbin
    Naomi Alpert
    Raja Flores
    Emanuela Taioli
    [J]. BMC Public Health, 21
  • [4] A risk index for COVID-19 severity is associated with COVID-19 mortality in New York City
    Lieberman-Cribbin, Wil
    Alpert, Naomi
    Flores, Raja
    Taioli, Emanuela
    [J]. BMC PUBLIC HEALTH, 2021, 21 (01)
  • [5] Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality
    Jin-jin Zhang
    Xiang Dong
    Guang-hui Liu
    Ya-dong Gao
    [J]. Clinical Reviews in Allergy & Immunology, 2023, 64 : 90 - 107
  • [6] Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality
    Zhang, Jin-jin
    Dong, Xiang
    Liu, Guang-hui
    Gao, Ya-dong
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 64 (01) : 90 - 107
  • [7] Obesity as an independent risk factor for COVID-19 severity and mortality
    Najafabadi, Borna Tadayon
    Rayner, Daniel G.
    Shokraee, Kamyar
    Shokraie, Kamran
    Panahi, Parsa
    Rastgou, Paravaneh
    Seirafianpour, Farnoosh
    Landi, Feryal Momeni
    Alinia, Pariya
    Parnianfard, Neda
    Hemmati, Nima
    Banivaheb, Behrooz
    Radmanesh, Ramin
    Alvand, Saba
    Shahbazi, Parmida
    Dehghanbanadaki, Hojat
    Shaker, Elaheh
    Same, Kaveh
    Mohammadi, Esmaeil
    Malik, Abdullah
    Srivastava, Ananya
    Nejat, Peyman
    Tamara, Alice
    Chi, Yuan
    Yuan, Yuhong
    Hajizadeh, Nima
    Chan, Cynthia
    Zhen, Jamie
    Tahapary, Dicky
    Anderson, Laura
    Apatu, Emma
    Schoonees, Anel
    Naude, Celeste E.
    Thabane, Lehana
    Foroutan, Farid
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (05):
  • [8] Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
    Li, Xiaochen
    Xu, Shuyun
    Yu, Muqing
    Wang, Ke
    Tao, Yu
    Zhou, Ying
    Shi, Jing
    Zhou, Min
    Wu, Bo
    Yang, Zhenyu
    Zhang, Cong
    Yue, Junqing
    Zhang, Zhiguo
    Renz, Harald
    Liu, Xiansheng
    Xie, Jungang
    Xie, Min
    Zhao, Jianping
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (01) : 110 - 118
  • [9] Diarrhea as an Independent Risk Factor for COVID-19 Severity and Inpatient Mortality
    Yost, Kelli C. Kosako
    Wassef, Wahid
    Rangan, Pooja
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S144 - S145
  • [10] A race to determine what drives COVID-19 severity
    Koutsakos, Marios
    Kedzierska, Katherine
    [J]. NATURE, 2020, 583 (7816) : 366 - 368